MoonLake Immunotherapeutics (MLTX)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $22k
- Jul 27 · Routine
- Form 4 sales
- 27
- On record
- Form 144 notices
- 13
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- Jul 27, 2026Routine
Reich Kristian, Chief Scientific Officer, sold under 0.1% of their holdings
$22k1,100 shares at $20.00
- Jul 22, 2026Routine
Reich Kristian, Chief Scientific Officer, sold 1.9% of their holdings
$1M52,448 shares at $20.02
- Jul 20, 2026Routine
Reich Kristian, Chief Scientific Officer, sold 1.6% of their holdings
$878k43,700 shares at $20.09
- Jul 15, 2026Routine
Reich Kristian, Chief Scientific Officer, sold 0.6% of their holdings
$322k16,105 shares at $20.01
- Jul 15, 2026Notice
Reich Kristian, Chief Scientific Officer, filed a notice to sell 150,000 shares
$2.9M150,000 shares
- Jul 10, 2026Routine
Santos da Silva Jorge, Chief Executive Officer, sold 3.6% of their holdings
$2M102,225 shares at $20.02
- Jul 1, 2026Routine
Santos da Silva Jorge, Chief Executive Officer, sold 1.6% of their holdings
$957k47,775 shares at $20.03
- Jun 30, 2026Notice
Santos da Silva Jorge, Chief Executive Officer, filed a notice to sell 150,000 shares
$3M150,000 shares
- Jun 22, 2026Routine
Bodenstedt Matthias, Chief Financial Officer, sold 3.4% of their holdings
$862k39,120 shares at $22.04
- Jun 18, 2026Routine
Bodenstedt Matthias, Chief Financial Officer, sold 1.5% of their holdings
$352k17,876 shares at $19.67
Every transaction
| Traded | Filed | Stock | Name | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | Jul 29, 2026 | MLTX | Reich Kristian | Chief Scientific Officer | Sold | 1,100 | $20.00 | $22k | 2.7M | SEC |
| Jul 22, 2026 | Jul 23, 2026 | MLTX | Reich Kristian | Chief Scientific Officer | Sold | 52,448 | $20.02 | $1M | 2.7M | SEC |
| Jul 20, 2026 | Jul 21, 2026 | MLTX | Reich Kristian | Chief Scientific Officer | Sold | 43,700 | $20.09 | $878k | 2.8M | SEC |
| Jul 15, 2026 | Jul 20, 2026 | MLTX | Reich Kristian | Chief Scientific Officer | Sold | 16,105 | $20.01 | $322k | 2.8M | SEC |
| Jul 10, 2026 | Jul 13, 2026 | MLTX | Santos da Silva Jorge | Chief Executive Officer | Sold | 102,225 | $20.02 | $2M | 2.8M | SEC |
| Jul 1, 2026 | Jul 2, 2026 | MLTX | Santos da Silva Jorge | Chief Executive Officer | Sold | 47,775 | $20.03 | $957k | 2.9M | SEC |
| Jun 22, 2026 | Jun 23, 2026 | MLTX | Bodenstedt Matthias | Chief Financial Officer | Sold | 39,120 | $22.04 | $862k | 1.1M | SEC |
| Jun 18, 2026 | Jun 18, 2026 | MLTX | Bodenstedt Matthias | Chief Financial Officer | Sold | 17,876 | $19.67 | $352k | 1.2M | SEC |
| Jun 17, 2026 | Jun 18, 2026 | MLTX | Phillips Andrew John | Director | AwardedOption to Buy | 22,195 | 22,195 | SEC | ||
| Jun 17, 2026 | Jun 18, 2026 | MLTX | Loy Spike | Director | AwardedOption to Buy | 22,195 | 22,195 | SEC | ||
| Jun 17, 2026 | Jun 18, 2026 | MLTX | Moukheibir Catherine | Director | AwardedOption to Buy | 22,195 | 22,195 | SEC | ||
| Jun 17, 2026 | Jun 18, 2026 | MLTX | Xavier Ramnik | Director | AwardedOption to Buy | 22,195 | 22,195 | SEC | ||
| Jun 17, 2026 | Jun 17, 2026 | MLTX | Reich Kristian | Chief Scientific Officer | Sold | 150,000 | $19.01 | $2.9M | 2.8M | SEC |
| Jun 17, 2026 | Jun 22, 2026 | MLTX | BVF Partners OS Ltd. | Director | AwardedOption to Buy | 22,195 | 22,195 | SEC | ||
| May 11, 2026 | May 13, 2026 | MLTX | Bodenstedt Matthias | Chief Financial Officer | Sold | 13,653 | $20.02 | $273k | 1.2M | SEC |
| Apr 14, 2026 | Apr 16, 2026 | MLTX | Bodenstedt Matthias | Chief Financial Officer | Sold | 2,426 | $19.56 | $47k | 1.2M | SEC |
| Apr 13, 2026 | Apr 14, 2026 | MLTX | Santos da Silva Jorge | Chief Executive Officer | Sold | 150,000 | $18.35 | $2.8M | 2.9M | SEC |
| Apr 10, 2026 | Apr 10, 2026 | MLTX | Bodenstedt Matthias | Chief Financial Officer | Sold | 87,795 | $18.95 | $1.7M | 1.2M | SEC |
| Mar 31, 2026 | Apr 2, 2026 | MLTX | Lampert Mark N | Director, 10% owner | Sold | 3.8M | $16.79 | $63M | 1M | SEC |
| Jan 7, 2026 | Jan 9, 2026 | MLTX | Bodenstedt Matthias | Chief Financial Officer | Awarded | 354,296 | 1.3M | SEC | ||
| Jan 7, 2026 | Jan 9, 2026 | MLTX | Santos da Silva Jorge | Chief Executive Officer | AwardedStock Option (Right to Buy) | 520,342 | 520,342 | SEC | ||
| Jan 7, 2026 | Jan 9, 2026 | MLTX | Reich Kristian | Chief Scientific Officer | AwardedStock Option (Right to Buy) | 520,342 | 520,342 | SEC | ||
| Dec 19, 2025 | Dec 22, 2025 | MLTX | Bodenstedt Matthias | Chief Financial Officer | Returned to the company | 294,473 | 0 | SEC | ||
| Dec 19, 2025 | Dec 22, 2025 | MLTX | Bodenstedt Matthias | Chief Financial Officer | ConvertedCommon shares, par value CHF 0.10 per share, of MoonLake AG | 8,754 | 0 | SEC | ||
| Dec 19, 2025 | Dec 22, 2025 | MLTX | Bodenstedt Matthias | Chief Financial Officer | Converted | 294,473 | 922,009 | SEC | ||
| Dec 19, 2025 | Dec 22, 2025 | MLTX | Reich Kristian | Chief Scientific Officer | Returned to the company | 35,389 | 0 | SEC | ||
| Dec 19, 2025 | Dec 22, 2025 | MLTX | Reich Kristian | Chief Scientific Officer | ConvertedCommon shares, par value CHF 0.10 per share, of MoonLake AG | 1,052 | 0 | SEC | ||
| Dec 19, 2025 | Dec 22, 2025 | MLTX | Reich Kristian | Chief Scientific Officer | Converted | 35,389 | 35,389 | SEC | ||
| Dec 19, 2025 | Dec 22, 2025 | MLTX | Santos da Silva Jorge | Chief Executive Officer | Returned to the company | 196,316 | 0 | SEC | ||
| Dec 19, 2025 | Dec 22, 2025 | MLTX | Santos da Silva Jorge | Chief Executive Officer | ConvertedCommon shares, par value CHF 0.10 per share, of MoonLake AG | 5,836 | 0 | SEC | ||
| Dec 19, 2025 | Dec 22, 2025 | MLTX | Santos da Silva Jorge | Chief Executive Officer | Converted | 196,316 | 3.1M | SEC | ||
| Dec 9, 2025 | Dec 10, 2025 | MLTX | Santos da Silva Jorge | Chief Executive Officer | Sold | 200,000 | $14.87 | $3M | 2.9M | SEC |
| Dec 9, 2025 | Dec 10, 2025 | MLTX | Reich Kristian | Chief Scientific Officer | Sold | 202,908 | $14.85 | $3M | 0 | SEC |
| Oct 8, 2025 | Oct 9, 2025 | MLTX | Bodenstedt Matthias | Chief Financial Officer | Bought | 10,870 | $9.09 | $99k | 627,536 | SEC |
| Sep 30, 2025 | Oct 1, 2025 | MLTX | Cormorant Global Healthcare Master Fund, LP | Other | Sold | 6.5M | $7.21 | $46.9M | 2M | SEC |
| Sep 2, 2025 | Sep 4, 2025 | MLTX | Reich Kristian | Chief Scientific Officer | Returned to the company | 48,978 | 35,389 | SEC | ||
| Sep 2, 2025 | Sep 4, 2025 | MLTX | Reich Kristian | Chief Scientific Officer | Converted | 48,978 | 202,908 | SEC | ||
| Jul 3, 2025 | Jul 7, 2025 | MLTX | Moukheibir Catherine | Director | Sold | 23,500 | $48.79 | $1.1M | 0 | SEC |
| Jul 3, 2025 | Jul 7, 2025 | MLTX | Moukheibir Catherine | Director | Exercised or settledOption to Buy | 23,500 | 21,500 | SEC | ||
| Jul 3, 2025 | Jul 7, 2025 | MLTX | Moukheibir Catherine | Director | Exercised options | 23,500 | 23,500 | SEC | ||
| Jun 5, 2025 | Jun 9, 2025 | MLTX | Sturge Simon | Director | AwardedOption to Buy | 6,682 | 6,682 | SEC | ||
| Jun 5, 2025 | Jun 9, 2025 | MLTX | Loy Spike | Director | AwardedOption to Buy | 6,682 | 6,682 | SEC | ||
| Jun 5, 2025 | Jun 9, 2025 | MLTX | Xavier Ramnik | Director | AwardedOption to Buy | 6,682 | 6,682 | SEC | ||
| Jun 5, 2025 | Jun 9, 2025 | MLTX | Moukheibir Catherine | Director | AwardedOption to Buy | 6,682 | 6,682 | SEC | ||
| Jun 5, 2025 | Jun 9, 2025 | MLTX | Phillips Andrew John | Director | AwardedOption to Buy | 6,682 | 6,682 | SEC | ||
| Jun 5, 2025 | Jun 9, 2025 | MLTX | Bvf INC/il | Director, 10% owner | AwardedOption to Buy | 6,682 | 6,682 | SEC | ||
| Feb 27, 2025 | Mar 3, 2025 | MLTX | Santos da Silva Jorge | Chief Executive Officer | Awarded | 95,763 | 3.1M | SEC | ||
| Feb 27, 2025 | Mar 3, 2025 | MLTX | Reich Kristian | Chief Scientific Officer | AwardedStock Option (Right to Buy) | 139,273 | 139,273 | SEC | ||
| Feb 27, 2025 | Mar 3, 2025 | MLTX | Bodenstedt Matthias | Chief Financial Officer | Awarded | 95,763 | 616,666 | SEC | ||
| Jan 20, 2025 | Sep 4, 2025 | MLTX | Reich Kristian | Chief Scientific Officer | ConvertedCommon shares, par value CHF 0.10 per share, of MoonLake AG | 1,456 | 1,052 | SEC |
Sales, notices and lockups (40)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | Jul 29, 2026 | Reich Kristian | MLTX | Chief Scientific Officer | Form 4 sale | 1,100 | $22k | 0.0% | Routine | SEC |
| Jul 22, 2026 | Jul 23, 2026 | Reich Kristian | MLTX | Chief Scientific Officer | Form 4 sale | 52,448 | $1M | 1.9% | Routine | SEC |
| Jul 20, 2026 | Jul 21, 2026 | Reich Kristian | MLTX | Chief Scientific Officer | Form 4 sale | 43,700 | $878k | 1.6% | Routine | SEC |
| Jul 15, 2026 | Jul 20, 2026 | Reich Kristian | MLTX | Chief Scientific Officer | Form 4 sale | 16,105 | $322k | 0.6% | Routine | SEC |
| Jul 15, 2026 | Jul 15, 2026 | Reich Kristian | MLTX | Chief Scientific Officer | Form 144 notice | 150,000 | $2.9M | Notice | SEC | |
| Jul 10, 2026 | Jul 13, 2026 | Santos da Silva Jorge | MLTX | Chief Executive Officer | Form 4 sale | 102,225 | $2M | 3.6% | Routine | SEC |
| Jul 1, 2026 | Jul 2, 2026 | Santos da Silva Jorge | MLTX | Chief Executive Officer | Form 4 sale | 47,775 | $957k | 1.6% | Routine | SEC |
| Jun 30, 2026 | Jun 30, 2026 | Santos da Silva Jorge | MLTX | Chief Executive Officer | Form 144 notice | 150,000 | $3M | Notice | SEC | |
| Jun 22, 2026 | Jun 23, 2026 | Bodenstedt Matthias | MLTX | Chief Financial Officer | Form 4 sale | 39,120 | $862k | 3.4% | Routine | SEC |
| Jun 18, 2026 | Jun 18, 2026 | Bodenstedt Matthias | MLTX | Chief Financial Officer | Form 4 sale | 17,876 | $352k | 1.5% | Routine | SEC |
| Jun 17, 2026 | Jun 17, 2026 | Reich Kristian | MLTX | Chief Scientific Officer | Form 4 sale | 150,000 | $2.9M | 5.0% | Routine | SEC |
| Jun 15, 2026 | Jun 15, 2026 | Reich Kristian | MLTX | Chief Scientific Officer | Form 144 notice | 150,000 | $2.9M | Notice | SEC | |
| May 11, 2026 | May 13, 2026 | Bodenstedt Matthias | MLTX | Chief Financial Officer | Form 4 sale | 13,653 | $273k | 1.2% | Routine | SEC |
| Apr 14, 2026 | Apr 16, 2026 | Bodenstedt Matthias | MLTX | Chief Financial Officer | Form 4 sale | 2,426 | $47k | 0.2% | Routine | SEC |
| Apr 13, 2026 | Apr 14, 2026 | Santos da Silva Jorge | MLTX | Chief Executive Officer | Form 4 sale | 150,000 | $2.8M | 4.9% | No plan | SEC |
| Apr 10, 2026 | Apr 10, 2026 | Bodenstedt Matthias | MLTX | Chief Financial Officer | Form 4 sale | 87,795 | $1.7M | 6.9% | Routine | SEC |
| Apr 10, 2026 | Apr 10, 2026 | Santos da Silva Jorge | MLTX | Chief Executive Officer | Form 144 notice | 150,000 | $2.8M | Notice | SEC | |
| Apr 9, 2026 | Apr 9, 2026 | Bodenstedt Matthias | MLTX | Chief Financial Officer | Form 144 notice | 160,870 | $3M | Notice | SEC | |
| Mar 31, 2026 | Apr 2, 2026 | Lampert Mark N | MLTX | Director, 10% owner | Form 4 sale | 3.8M | $63M | 78.3% | Unusual | SEC |
| Mar 31, 2026 | Mar 31, 2026 | Bvf Partners L P/il | MLTX | 10% Stockholder, Affiliate of Director | Form 144 notice | 3.8M | $63.5M | Notice | SEC | |
| Dec 9, 2025 | Dec 10, 2025 | Santos da Silva Jorge | MLTX | Chief Executive Officer | Form 4 sale | 200,000 | $3M | 6.5% | Unusual | SEC |
| Dec 9, 2025 | Dec 10, 2025 | Reich Kristian | MLTX | Chief Scientific Officer | Form 4 sale | 202,908 | $3M | 100.0% | Unusual | SEC |
| Dec 8, 2025 | Dec 8, 2025 | Santos da Silva Jorge | MLTX | Chief Executive Officer | Form 144 notice | 200,000 | $3M | Notice | SEC | |
| Dec 8, 2025 | Dec 8, 2025 | Reich Kristian | MLTX | Chief Scientific Officer | Form 144 notice | 202,908 | $3M | Notice | SEC | |
| Sep 30, 2025 | Oct 1, 2025 | Cormorant Global Healthcare Master Fund, LP | MLTX | Other | Form 4 sale | 6.5M | $46.9M | 76.5% | Unusual | SEC |
| Jul 3, 2025 | Jul 7, 2025 | Moukheibir Catherine | MLTX | Director | Form 4 sale | 23,500 | $1.1M | 100.0% | Unusual | SEC |
| Jul 3, 2025 | Jul 3, 2025 | Moukheibir Catherine | MLTX | Director | Form 144 notice | 23,500 | $1.1M | Notice | SEC | |
| Oct 4, 2024 | Oct 8, 2024 | Sturge Simon | MLTX | Director | Form 4 sale | 171,000 | $9.2M | 49.9% | Unusual | SEC |
| Oct 4, 2024 | Oct 8, 2024 | Bvf I Gp LLC | MLTX | Director, 10% owner | Form 4 sale | 2M | $100M | 60.8% | Unusual | SEC |
| Feb 29, 2024 | Feb 29, 2024 | Santos da Silva Jorge | MLTX | Chief Executive Officer | Form 4 sale | 123,615 | $6.8M | 4.0% | Routine | SEC |
| Feb 28, 2024 | Feb 29, 2024 | Reich Kristian | MLTX | Chief Scientific Officer | Form 4 sale | 118,922 | $6.5M | 3.9% | Routine | SEC |
| Feb 21, 2024 | Feb 23, 2024 | Santos da Silva Jorge | MLTX | Chief Executive Officer | Form 4 sale | 1,125 | $62k | 0.0% | Routine | SEC |
| Feb 21, 2024 | Feb 22, 2024 | Reich Kristian | MLTX | Chief Scientific Officer | Form 4 sale | 21,078 | $1.2M | 0.7% | Routine | SEC |
| Feb 20, 2024 | Feb 20, 2024 | Santos da Silva Jorge | MLTX | Chief Executive Officer | Form 4 sale | 60,000 | $3.6M | 1.9% | Routine | SEC |
| Feb 16, 2024 | Feb 16, 2024 | Reich Kristian | MLTX | Chief Scientific Officer | Form 4 sale | 60,000 | $3.7M | 2.0% | Routine | SEC |
| Feb 15, 2024 | Feb 15, 2024 | Santos da Silva Jorge | MLTX | Chief Executive Officer | Form 144 notice | 200,000 | $12.8M | Notice | SEC | |
| Feb 14, 2024 | Feb 14, 2024 | Reich Kristian | MLTX | Chief Scientific Officer | Form 144 notice | 200,000 | $12.6M | Notice | SEC | |
| Dec 20, 2023 | Dec 21, 2023 | Bodenstedt Matthias | MLTX | Chief Financial Officer | Form 4 sale | 100,000 | $5.9M | 16.1% | Routine | SEC |
| Dec 20, 2023 | Dec 20, 2023 | Bodenstedt Matthias | MLTX | Chief Financial Officer | Form 144 notice | 5,264 | $312k | Notice | SEC | |
| Dec 19, 2023 | Dec 19, 2023 | Bodenstedt Matthias | MLTX | Chief Financial Officer | Form 144 notice | 94,736 | $5.6M | Notice | SEC |